Dl-Phenylalanine

Dl-Phenylalanine

SCHEMBL4283680

CC(C)C(N)C(=O)O.CC(C)C(N)C(=O)O.NC(Cc1ccccc1)C(=O)O.NC(Cc1ccccc1)C(=O)O

nearest known ligand 0.76

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 7/20 0.76
ALPI P09923 1/20 0.76
PKM P14618 1/20 0.76
PTGS1 P23219 1/20 0.76
XIAP P98170 1/20 0.76
SLC1A3 P43003 2/20 0.59
SLC1A2 P43004 2/20 0.59
SLC1A1 P43005 2/20 0.59
SLC15A1 P46059 1/20 0.51
NOS3 P29474 1/20 0.51
NOS1 P29475 1/20 0.51
NOS2 P35228 1/20 0.51
SLC6A2 P23975 2/20 0.50
TAAR1 Q96RJ0 2/20 0.50
ANPEP P15144 2/20 0.50
RNPEP Q9H4A4 2/20 0.50
DNPEP Q9ULA0 2/20 0.50
MAOA P21397 1/20 0.50
SLC6A4 P31645 1/20 0.50
SLC6A3 Q01959 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenylalanine SCHEMBL531086 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
D-Phenylalanine SCHEMBL28257181 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
D-Phenylalanine SCHEMBL28257178 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL28144022 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL1679190 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL6237224 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL8595582 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL4283687 1.00 SLC7A5 (0.76) SLC7A5ALPIPKMPTGS1XIAP
Dl-Phenylalanine SCHEMBL6535452 0.97 SLC7A5 (0.71) SLC7A5ALPIPKMPTGS1XIAP
Phenylalanine SCHEMBL6274269 0.97 SLC7A5 (0.71) SLC7A5ALPIPKMPTGS1XIAP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106620845-B Injectable bone material and method for preparing same 深圳清华大学研究院 2020-07-07 CN claimed
US-20210355166-A1 ANALGESICS AND METHODS OF USE THEREOF UNIV SYDNEY (AU) 2021-11-18 US disclosed
EP-3802560-A1 ANALGESICS AND METHODS OF USE THEREOF The University of Sydney (AU) 2021-04-14 EP disclosed
CN-112469729-A Analgesic and method of use 悉尼大学 2021-03-09 CN disclosed
CN-106620845-B Injectable bone material and method for preparing same 深圳清华大学研究院 2020-07-07 CN disclosed
WO-2019227163-A1 ANALGESICS AND METHODS OF USE THEREOF THE UNIVERSITY OF SYDNEY (AU) 2019-12-05 WO disclosed
WO-2009153565-A1 METHOD FOR AIDING THE DIAGNOSIS OF BILIARY ATRESIA BY DETERMINING THE LEVEL OF ADMA IN A BLOOD SAMPLE KING'S COLLEGE LONDON (GB) 2009-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210355166-A1 ANALGESICS AND METHODS OF USE THEREOF OPRL1, OPRD1, VIP SLC7A5 1230/4885ALPI 1519/4885PKM 2580/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.